Survey Results: Biosimilars
Survey Results: Biosimilars The Gastrointestinal Society represents inflammatory bowel disease (IBD) patients on a variety of health care fronts, including access to medications. During the first part of 2015, we hosted a survey on our English (www.badgut.org) & French (www.mauxdeventre.org) websites to help understand IBD patientsโ opinions and outlooks regarding biosimilars (subsequent entry biologics/SEBs). To [...]